治疗性血交换对组织因子和组织因子通路抑制剂在败血症冲击中的作用
Klaus Stahl1, Georg F Lehner2, Pedro David Wendel-Garcia3
1Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, Hannover, Germany.
Critical care (London, England)
|October 31, 2024
概括
治疗性血交换 (TPE) 显著降低了组织因子 (TF) 和组织因子通路抑制剂 (TFPI). 较高的基线TF和TFPI预测TPE后乳酸水平的降低更大.
科学领域:
- 败血症的研究研究.
- 凝血障碍 凝血障碍 凝血障碍
- 血交换疗法是一种血交换疗法.
背景情况:
- 败血症诱导的凝血病包括增加的组织因子 (TF) 和组织因子通路抑制剂 (TFPI).
- 高水平的TF和TFPI与传播的血管内凝血,器官功能障碍和败血症死亡率相关.
- 目前的治疗方法并没有专门针对毒症中的TF-TFPI轴.
研究的目的:
- 调查治疗性血交换 (TPE) 对败血症休克中TF和TFPI水平的影响.
- 为了确定TPE是否可以恢复血蛋白平衡,并限制败血症引起的凝血病.
- 探索基线TF和TFPI度作为对TPE临床反应的预测指标.
主要方法:
- 在51名患有早期,严重败血症休克的患者中进行了聚合后期分析.
- 标准护理 (SOC) 和 SOC + TPE 组之间的比较.
- 血TF和TFPI在基线和输入后6小时的测量;乳酸水平在24小时内进行监测.
主要成果:
- 与SOC相比,TPE显著降低了循环中的TF和TFPI度.
- 接受TPE治疗的患者表现出持续的乳酸减少,无论基线TF/TFPI水平如何.
- 较高的基线TF和TFPI预测TPE组的乳酸减少更大.
结论:
- 辅助TPE有效地去除了败血症休克时的TF和TFPI,可能改善了血液动力学.
- 基线提升的TF和TFPI可以预测在败血症休克中对TPE的治疗反应.
- 这些发现支持TPE作为一种潜在的治疗策略,并建议对未来的临床试验进行预测丰富.
相关概念视频
01:20Extrinsic and Intrinsic Pathways of Hemostasis
5.8K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
5.8K
01:16Clot Retraction and Fibrinolysis
4.2K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
4.2K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
624
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
624
01:24Inflammatory Response II: Inflammatory Exudate and Tissue Repair
4.8K
The immune system's inflammatory response destroys the invading pathogen, permitting the tissue to heal. The changes during the cellular and vascular stages allow exudate formation at the site of inflammation. The inflammatory exudate released from the wound has high protein content and a specific gravity above 1.020.
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
4.8K